CHEOY:OTCMKTS
Cochlear Ord ADR
$45.44
arrow_upward
+1.61%(+0.72) 1D
Okt 16, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa CHEOY...
Buksan
$43.84
Mataas
$46.04
Mababa
$43.84
Mkt. cap
8.67B
Avg. na dami
18.60K
Dami
29.16K
Mataas nang 52-wk
$98.49
Mababa nang 52-wk
$31.82
Beta
0.68
Mga natitirang share
130.80M
Bilang ng mga empleyado
5K
Buksan
$43.84
Mataas
$46.04
Mababa
$43.84
Mkt. cap
8.67B
Avg. na dami
18.60K
Dami
29.16K
Mataas nang 52-wk
$98.49
Mababa nang 52-wk
$31.82
Beta
0.68
Mga natitirang share
130.80M
Bilang ng mga empleyado
5K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Kalkine Media
·
6 oras ang nakalipas
Why Are Cochlear Shares Struggling after Class Action (ASX:COH)?
Profile
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
Tungkol sa Cochlear Ord ADR
CEODig Howitt
Mga Empleyado5.4K
Itinatag1981
HeadquartersSydney, New South Wales, Australia
Sektor-
Websitecochlear.com